The key difference lies in how selectively and efficiently they may interact with that receptor, which is an active area of ongoing research
Parker VER, Robertson D, Wang T, Hornigold DC, Petrone M, Cooper AT, et al
Patients with a history of eating disorders, who are pregnant or breastfeeding or have hypersensitivity to specific medications are not eligible
These findings are consistent with frontal and brainstem activations occurring during opioid, placebo (Petrovic et al., 2002), and other types of analgesia and in individuals resilient to depression (Ong et al., 2019
112,113 Several clinical studies support the cardiovascular benefits of GLP-1 RAs, as there is evidence from meta-analyses of cardiovascular outcome trials illustrating that GLP-1 RA therapy lowers the risk of major adverse cardiovascular events by 14% and all-cause mortality by 12% in patients with T2D